معرفی
Douglas W. Allan is a Professor in the Department of Cellular & Physiological Sciences at the University of British Columbia's Faculty of Medicine. His research focuses on gene regulation in neurons and the use of Drosophila models for clinical variant interpretation in neurological disorders.
His educational background includes:
- BSc (Honors) from Aberdeen University (1988-1992)
- MSc from Aberdeen University, Scotland (1992-1993)
- PhD from the University of Alberta (1994-2000)
- Postdoctoral training at Harvard Medical School (2000-2005)
Dr. Allan's research explores transcriptional mechanisms controlling neuronal identity and synaptic function through retrograde BMP signaling at the neuromuscular junction. His lab develops Drosophila assays for clinical interpretation of human gene variants in autism, Alzheimer's, and rare diseases, leveraging evolutionary conservation of molecular pathways between Drosophila and humans for scalable variant analysis.
His publication portfolio demonstrates consistent focus on neuronal development and disease mechanisms using Drosophila models, with recurring themes in synaptic maturation, motor neuron survival, and functional genomics of disease-associated variants across neurodevelopmental and neurodegenerative conditions.
Dr. Allan's scientific contributions have been recognized with prestigious awards:
- Tula Foundation Investigator (Brain Research Centre)
- CIHR New Investigator
- MSFHR Scholar
- EJLB Scholar
As principal investigator, Dr. Allan directs an active research program funded through multiple scholar awards, mentoring graduate students and postdoctoral fellows in molecular neuroscience. His lab operates within UBC's Life Sciences Institute infrastructure with formal affiliations to the Djavad Mowafaghian Centre for Brain Health.
The Allan Lab maintains specialized research teams targeting Alzheimer's, Arthritis, Autism, Cancer, and Rare Diseases, utilizing Drosophila and mouse models to investigate gene regulation in neuronal development, maintenance, and disease pathogenesis with direct clinical translation applications.
